This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The fear of having another heartattack was a major ongoing stressor for heartattack survivors, according to a preliminary study to be presented at the American Heart Association's Scientific Sessions 2024, held Nov. 16–18, 2024, in Chicago.
A new, rapid blood test that spots whether people are having a heartattack could improve the treatment of people presenting with chest pain at emergency departments, according to late-breaking research presented in a Hot Line Session Sept. 2 at this year's ESC Congress 2024.
Heartattack risk almost doubles in the first year after a stroke or when combined with a tear in a neck artery wall; however, a tear without a stroke does not seem to raise heartattack risk, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2024.
tim.hodson Mon, 11/18/2024 - 10:55 Nov. Patient Demographics: Patients on APT had a higher rate of coronary artery disease (70% vs. 42%), previous heartattacks (36% vs. 16%), and peripheral artery disease (15% vs. 11%). For more information, please visit anthostherapeutics.com.
milla1cf Wed, 02/14/2024 - 18:21 February 14, 2024 — Efemoral Medical , developer of advanced interventional bioresorbable therapies, today announced that the United States Food & Drug Administration ( FDA ) has granted its novel Efemoral Vascular Scaffold System (EVSS) Breakthrough Device status for the treatment of de novo or restenotic lesions (..)
hospitals meet the national average of mortality and payment rates used to calculate value of care for heartattack patients, according to CMS data published Oct. 30, 2024. The majority of U.S.
DALLAS, May 14, 2024 — Living with a chronic medical condition after surviving a heartattack or stroke may come with additional health and personal care needs. Often survivors must rely on a family member or close friend to help. However, there’s a.
(RCE) is an innovative artificial intelligence (AI) based medical technology company dedicated to early heartattack detection. milla1cf Mon, 04/22/2024 - 15:05 April 22, 2024 — At the annual American College of Cardiology conference ( ACC.24 Dohad , MD, as principal investigator.
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heartattack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.
The study focused on patients who underwent PCI for acute coronary syndromes (ACS)—life-threatening conditions which include heartattacks and chest pain caused by decreased blood flow to the heart—with stents containing drugs to prevent further plaque buildup.
Caristo Diagnostics Limited has announced the results of a landmark clinical study published in The Lancet that support the ability of Caristo's CaRi-Heart AI technology to quantify coronary artery inflammation and accurately predict cardiac events. Coronary inflammation is a crucial piece of the puzzle in predicting heartattack risk.
Using artificial intelligence (AI) to aid clinical decision making in identifying and managing myocardial infarction (MI; heartattack) in patients presenting to the emergency department (ED) with suspected cardiac conditions does not improve cardiovascular outcomes. 2 Sept.).
Youth with high blood pressure are nearly four times more likely to be at long-term risk of serious heart conditions including stroke and heartattack, according to a new study. The research, led by McMaster University, will be presented at the Pediatric Academic Societies (PAS) 2024 Meeting, held May 2–6 in Toronto.
Pocket-Sized Kardia 12L ECG System milla1cf Tue, 06/25/2024 - 18:55 June 25, 2024 — AliveCor , the global leader in AI -powered cardiology, today announced the U.S. This is the world’s first AI that can detect life-threatening cardiac conditions, including heartattacks, using a reduced leadset.
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.
All patients who have had a heartattack are typically treated using beta blockers. According to a Swedish study conducted earlier in 2024, this drug is unlikely to be needed for those heart patients who have normal pumping ability.
milla1cf Sun, 04/07/2024 - 18:20 April 7, 2024 — An estimated 1 in 5 U.S. adults—and more than 2 in 5 adults aged 60 years and older—have elevated triglycerides, also known as hypertriglyceridemia , putting them at an increased risk for heartattacks and stroke.
milla1cf Sun, 04/07/2024 - 18:09 April 7, 2024 — Among patients at high or very high risk for a heartattack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or “bad” cholesterol, levels by more than half on average, compared with a placebo.
mtaschetta-millane Wed, 07/10/2024 - 09:02 July 10, 2024 — CellProthera , a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia, Inc. , The ProtheraCytes, which are autologous, expanded CD34+ stem cells, were well tolerated with no unexpected serious adverse events reported.
milla1cf Thu, 06/20/2024 - 19:40 June 20, 2024 — A programing algorithm, being tested by HonorHealth Research Institute for those patients with new or recently installed pacemakers, is designed so the device not only provides a steady heartbeat, but also controls high blood pressure. You just turn it on, and it works,” Dr.
Getty Images milla1cf Thu, 05/16/2024 - 15:37 May 16, 2024 — People were more likely to develop a type of treatment-resistant hypertension when they experienced adverse effects of economic and social conditions that influence individual and group differences in health status, known as social determinants of health.
milla1cf Fri, 03/01/2024 - 08:50 March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. vs. 3.9%, P=0.001), a 49% risk reduction in heartattack at the target vessel (6.4% ISR is the obstruction or narrowing of a stented vessel by plaque or scar tissue. vs. 28.7%; P=0.006).
milla1cf Wed, 06/19/2024 - 20:57 June 19, 2024 — When electrophysiologist Eugenio Cingolani, MD , isn’t seeing patients, he can usually be found in his laboratory, investigating improved treatments for heart rhythm disorders. Q: Tell us about VT and why it can be such a serious heart condition? Eugenio Cingolani, MD.
This is known as a "leaky valve" or MR. Mitral valve disease has many causes, such as heartattack and other types of heart disease, a heart condition present at birth, certain infections, or simply older age.
milla1cf Mon, 03/18/2024 - 08:00 March 18, 2024 — The Smidt Heart Institute at Cedars-Sinai recently became one of four institutions in the U.S. and the first on the West Coast to use a new device aimed at lowering blood pressure in patients with difficult-to-treat hypertension.
Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. A lot of our approaches in stroke treatment were learned from how we treat heartattacks.
An improved understanding of heart development could help inform new clinical strategies in managing congenital heart diseases, which are the most common type of birth defects, said research team leader Shang Wang from Stevens Institute of Technology. Express, 16, 499-519 (2024). The clipping spline is open-source at: [link].
2 If this was a simple issue to solve, one could ask – what do we need to ensure that the 60% to 80% of people with hypertension who are at high risk of a stroke, heartattack and other consequences, are not left behind? However, more recently these organizations developed two independent guidelines in 2023 and 2024.
milla1cf Thu, 06/06/2024 - 21:44 June 6, 2024 — A new, robotic approach to heart bypass surgery is now being offered to patients at University Hospitals ( UH ) with great success.
Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The heart has four valves (aortic, mitral, pulmonic, and tricuspid) that open and close to move blood through the heart and to the rest of the body. Image by Getty.
Stroke, Volume 55, Issue Suppl_1 , Page AWP64-AWP64, February 1, 2024. Introduction:While timely therapy of neurologic and cardiac emergencies can improve outcomes, patients often fail to identify acute events resulting in delays in seeking emergency care.
tim.hodson Fri, 10/04/2024 - 11:39 Oct. 2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heartattacks and heart failure.
High levels of triglycerides and the lipid particles on which they are carried in the blood can contribute to the formation of “plaques” in the arteries that impede blood flow and can lead to heartattacks and strokes.
tim.hodson Mon, 09/16/2024 - 10:49 Sept. 16, 2024 – Shockwave Medical, Inc., 1 People suffering from PAD have not only impaired quality of life but also increased risk of heartattack or stroke. part of Johnson & Johnson MedTech* has announced the full U.S. Food and Drug Administration (FDA).
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S.
I had had a heartattack previously. Navigating Post-Stroke Recovery at Home: One Patient's Experience A ”mildly impaired” stroke patient with atrial fibrillation who was discharged reported, “I knew my local pharmacist, and they knew my prescriptions. I couldn’t dispense my medications into daily doses.
tim.hodson Tue, 09/24/2024 - 15:46 Sept. 24, 2024 — Thrombolytic Science, LLC (TSI) has announced that the U.S. A successful proof of concept clinical trial using native prourokinase in heartattack patients, preceded by a mini dose of tPA was previously published, the PATENT trial.
The father of three and grandfather of eight, he has had three heartattacks in the last three years, which led to congestive heart failure. “I and Allina Health. Patient Experience The patient who received the Barostim implant is 75-year-old James Bennett of Brainerd, Minnesota.
Wegovy’s recent FDA approval expansion for CVD events and last week’s Medicare Part D policy expansion both come in response to the SELECT trial , which found that Wegovy slashed patients’ major cardiac event risks by 20% over five years, while cutting non-fatal heartattacks by 28% and reducing cardiovascular mortality by 15%.
Having elevated Lp(a) can increase risk of heartattack, stroke, and peripheral artery disease.It A configurable measure report including Lp(a) measurement obtained and Lp(a) level was added in April 2024.Methods:Beginning is estimated that as many as 20% of the American population have elevated Lp(a) levels.
Circulation, Volume 150, Issue Suppl_1 , Page A4140513-A4140513, November 12, 2024. Aims:Asian Americans experience disproportionate burdens of cardiovascular risk factors and cardiovascular disease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied.
tim.hodson Tue, 10/01/2024 - 10:50 PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy, showing specific plaque type and amount across various views to inform physician assessment of risk and patient-specific treatment pathway.
Reduction in admissions for stroke recurrence or related to stroke, (heartattack, angina, peripheral embolism, etc.): Stroke, 30days: -100%; Related to stroke, (365d: -47,7%; 30d: -57,0%). Reduction in cardiovascular admissions ( 30d: -100%; 365d: -31,4%).
The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heartattack 2. 2024 Jan 14. 8 The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins. 2024 Jan;388:117397. Obesity (Silver Spring).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content